Attend SITC's Comprehensive Cancer Immunotherapy Advanced Training Program Feb. 18-22, 2019
Inspire the Next Generation of Cancer Immunotherapy Leaders
Advance the science of cancer immunotherapy and help young investigators tackle hurdles facing the field with a year-end gift to the SITC Forward Fund.
Pittsburgh | Sacramento, Calif. | Houston
Join a SITC Professional Interest Community
Create new collaborations, build your professional network and discuss the latest research trends in SITC Professional Interest Communities.
See members discuss the benefits of a SITC membership in this new video.
Explore resources and educational opportunities for cancer patients and those who advocate for them.
Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.
Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.
This conference will bring together talented T cell-based scientists and will promote discussions/collaborations for therapeutic intervention in the setting of tumor immunology. Join Wolchok, Allison, Schreiber, June, Greenberg and more for this unique ...
REGISTER NOW: mskcc.org/cartcell Memorial Sloan Kettering Cancer Center invites you to attend Clinical Application of CAR T Cells taking place on March 14-15, 2019 at Zuckerman Research Center in New York City. For more information or to register, ...
Hi ladies Anyone in the group with interest in head and neck cancers and phase 1 clinical trials? Would love to explore ideas and potential collaborations. Priscila ------------------------------ Priscila Goncalves Associate Director Center for Novel ...
Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.
An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.
It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com